Bioactivities and Action Mechanisms of Active Compounds from T on Human Lung Cancer Cells

Overview

Journal Biomedicine (Taipei)

Specialty Biomedical Engineering

Date 2022 Feb 28

PMID 35223403

Authors

Yuh-Fung Chen

Wen-Hsin Chang

Huei-Yann Tsai

Min-Min Lee

Tian-Shang Wu

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer is the leading cause of death in Taiwan for years. Besides the currently used chemotherapy, herbal medicine may play a role in the treatment of lung cancer. Thunb (HC), one of the frequently used herbal medicine in Taiwan, has been widely used in various diseases. Review from literatures, HC has many effects, including anti-inflammatory, anti-viral, anti-bacterial, anti-SARS, and anti-tumor activities. However, there is no literatures describe its active compounds on lung cancer. This present study aims to evaluate the possible effect and action mechanism of active compounds from HC (aristolactam BII, aristolactam AII, and noraristolodione) on lung cancer. A549 lung cancer cell line was used to evaluate the effects of HC on the cell viability and possible anti-tumor effects.

Methods: We used A549 cells in the evaluation of anticancer activity. Cell viability, cell cycle, cell apoptosis and apoptosis related protein expression were studied.

Results: Active compounds from HC significantly inhibited A549 cell viability and induced accumulation of cell cycle at S or G2/M phase on A549 cells in a concentration-dependent manner, and induced A549 arrest at S or G2/M phase via increasing p21, p27, p53 and reducing cyclin-E, -A, cyclin-dependent kinase 2 (CDK2), cdc-2 (CDK1) protein expression. Additionally, HC induced A549 cell late apoptosis by up-regulating caspase-3, -8, Bax and decreasing Bcl-2 protein expression.

Conclusions: The anti-tumor effects of aristolactam BII, aristolactam AII, and noraristolodione on human lung carcinoma A549 cells were via cell cycle arrest and apoptosis.

Citing Articles

Imperatorin ameliorates pulmonary fibrosis via GDF15 expression.

Tsai C, Chen Y, Li Y, Wu C, Chang P, Yeh W Front Pharmacol. 2023; 14:1292137.

PMID: 38111379 PMC: 10725920. DOI: 10.3389/fphar.2023.1292137.

ANGPTL2 promotes VEGF-A synthesis in human lung cancer and facilitates lymphangiogenesis.

Liu P, Jiang Y, Chang A, Huang C, Fong Y, Guo J Aging (Albany NY). 2023; 15(5):1652-1667.

PMID: 36917086 PMC: 10042695. DOI: 10.18632/aging.204581.

Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity.

Mhone T, Chen M, Kuo C, Shih T, Yeh C, Wang T Int J Biol Sci. 2022; 18(9):3636-3652.

PMID: 35813479 PMC: 9254481. DOI: 10.7150/ijbs.71870.

References

Lu H, Liang Y, Yi L, Wu X . Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol. 2005; 104(1-2):245-9. PMC: 7127264. DOI: 10.1016/j.jep.2005.09.012. View

Chang J, Chiang L, Chen C, Liu L, Wang K, Lin C . Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb. Am J Chin Med. 2001; 29(2):303-12. DOI: 10.1142/S0192415X01000320. View

Kim S, Ryu S, No J, Choi S, Kim Y . Cytotoxic alkaloids from Houttuynia cordata. Arch Pharm Res. 2002; 24(6):518-21. DOI: 10.1007/BF02975156. View

Chiang L, Chang J, Chen C, Ng L, Lin C . Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med. 2003; 31(3):355-62. DOI: 10.1142/S0192415X03001090. View

Liu X, Wang B, Fu X . [Clinical study on treatment of advanced non-small cell lung cancer with Chinese herbal medicine combined with synchronous radio- and chemotherapy]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002; 20(6):427-9. View

Toda S . Antioxidative effects of polyphenols in leaves of Houttuynia cordata on protein fragmentation by copper-hydrogen peroxide in vitro. J Med Food. 2005; 8(2):266-8. DOI: 10.1089/jmf.2005.8.266. View

Chen Y, Yang J, Chang W, Tsai S, Peng S, Zhou Y . Houttuynia cordata Thunb extract modulates G0/G1 arrest and Fas/CD95-mediated death receptor apoptotic cell death in human lung cancer A549 cells. J Biomed Sci. 2013; 20:18. PMC: 3610241. DOI: 10.1186/1423-0127-20-18. View

Wierod L, Rosseland C, Lindeman B, Oksvold M, Grosvik H, Skarpen E . Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes. Oncogene. 2007; 27(19):2763-71. DOI: 10.1038/sj.onc.1210937. View

Ng L, Yen F, Liao C, Lin C . Protective effect of Houttuynia cordata extract on bleomycin-induced pulmonary fibrosis in rats. Am J Chin Med. 2007; 35(3):465-75. DOI: 10.1142/S0192415X07004989. View

10.

Huang C, Ju D, Chang C, Reddy P, Velmurugan B . A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei). 2017; 7(4):23. PMC: 5682982. DOI: 10.1051/bmdcn/2017070423. View

11.

Lin T, Liu Y, Jheng J, Tsai H, Jan J, Wong W . Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities. Am J Chin Med. 2009; 37(1):143-58. DOI: 10.1142/S0192415X09006734. View

12.

Zuckerman V, Wolyniec K, Sionov R, Haupt S, Haupt Y . Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol. 2009; 219(1):3-15. DOI: 10.1002/path.2584. View

13.

Rixe O, Spano J, Seigneur J . [Chemotherapy of non-small cell lung cancer: non-cisplatin based combinations]. Anticancer Drugs. 2001; 11 Suppl 1:S29-33. View

14.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

15.

Chen Y, Liu J, Chen C, Chao P, Chang T . A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo). 2004; 49(5):327-33. DOI: 10.3177/jnsv.49.327. View

16.

Kuo C, Liao Y, Kuo L, Tsai H, Chang W, Yen Y . Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost. J Formos Med Assoc. 2019; 119(12):1731-1741. DOI: 10.1016/j.jfma.2019.08.023. View

17.

Lau K, Lee K, Koon C, Cheung C, Lau C, Ho H . Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol. 2008; 118(1):79-85. PMC: 7126383. DOI: 10.1016/j.jep.2008.03.018. View

18.

Katiyar S, Meeran S, Katiyar N, Akhtar S . p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog. 2008; 48(1):24-37. DOI: 10.1002/mc.20453. View